Citalopram HydrobromideThird Party Manufacturing in India

Citalopram Hydrobromide is a selective serotonin reuptake inhibitor (SSRI) that works by enhancing serotonergic activity in the central nervous system. Serotonin, also known as 5-hydroxytryptamine (5-HT), is a neurotransmitter that regulates mood, emotion, sleep, appetite, and other cognitive functions. Citalopram binds to the serotonin transporter (SERT) protein on the presynaptic neuronal membrane, blocking the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. This inhibition increases the concentration of serotonin available in the synapse, allowing prolonged activation of postsynaptic serotonin receptors and thereby enhancing neurotransmission. Citalopram is highly selective for serotonin reuptake inhibition with minimal effects on norepinephrine and dopamine reuptake, which distinguishes it from older classes of antidepressants like tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). It also has negligible affinity for histaminergic, cholinergic, adrenergic, and GABA receptors, resulting in a favourable side effect profile compared to TCAs. The therapeutic response typically begins within one to two weeks of treatment, with full antidepressant effects developing over four to six weeks as adaptive changes occur in serotonin receptor density and downstream signalling pathways.

Therapeutic Uses

Citalopram Hydrobromide is prescribed for the treatment of psychiatric conditions:

• Major Depressive Disorder (MDD): First-line treatment for moderate to severe depression, effective in improving mood, sleep, appetite, energy levels, and reducing suicidal ideation.
• Panic Disorder: Reduces the frequency and severity of panic attacks, with or without agoraphobia.
• Obsessive-Compulsive Disorder (OCD): Helps reduce the frequency and intensity of obsessive thoughts and compulsive behaviours.
• Anxiety Disorders: Used off-label for generalized anxiety disorder, social anxiety disorder, and post-traumatic stress disorder.
• Premenstrual Dysphoric Disorder (PMDD): Sometimes prescribed for severe mood disturbances related to the menstrual cycle.

Why Manufacturers Choose Citalopram Hydrobromide

Citalopram is one of the most prescribed antidepressants globally and is included in the WHO Essential Medicines List. The molecule is well-established with a large body of clinical evidence supporting its safety and efficacy. Indian manufacturers produce citalopram hydrobromide tablets in 10mg, 20mg, and 40mg strengths, serving both the domestic psychiatric market and export channels. The growing awareness of mental health issues in India and developing countries has led to increased demand for affordable generic antidepressants. Citalopram’s favourable tolerability profile, once-daily dosing, and availability in multiple strengths make it a strong candidate for contract manufacturing and PCD franchise distribution.

This makes Citalopram Hydrobromide one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.